Efficacy and Safety of Oral Alendronate Treatment in Children and Adolescents with Osteoporosis

Articles in the same Issue

1. Title
2. Contents
3. REVIEW
4. Growth Hormone and Premature Atherosclerosis in Childhood Obesity
5. COMMENTARY
6. The Growing Child with Thalassaemia
7. ORIGINAL CONTRIBUTIONS
8. Impact of Long-term Iron Chelation Therapy on Growth and Endocrine Functions in Thalassaemia
9. Diagnosis of Idiopathic Growth Hormone Deficiency: Contributions of Data on the Acid-labile Subunit, Insulin-like Growth Factor (IGF)-I and-II, and IGF Binding Protein-3
10. Congenital Combined Pituitary Hormone Deficiency Attributable to a Novel PROP1 Mutation (467insT)
11. The Psychosocial Impact of Klinefelter Syndrome-A 10 Year Review
12. Diagnostic Value of Fine-Needle Aspiration Biopsy of Thyroid Nodules in Children and Adolescents
13. Thyroid Autoimmunity in Children with Coexisting Type 1 Diabetes Mellitus and Celiac Disease: A Multicenter Study
14. Efficacy and Safety of Oral Alendronate Treatment in Children and Adolescents with Osteoporosis
15. Effect of Carbamezapine and Valproic Acid on Bone Mineral Density, IGF-I and IGFBP-3
16. PATIENT REPORTS
17. Worster-Drought Syndrome (Congenital Bilateral Perisylvian Syndrome) with Posterior Pituitary Ectopia, Pituitary Hypoplasia, Empty Sella and Panhypopituitarism: A Patient Report
18. Preclinical Diagnosis of Testotoxicosis in a Boy with an Activating Mutation of the Luteinizing Hormone Receptor
19. LETTER TO THE EDITOR
20. Recurrent Intracranial Hypertension Induced by Growth Hormone Therapy
21. Calendar